Cargando…
A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392678/ https://www.ncbi.nlm.nih.gov/pubmed/32727596 http://dx.doi.org/10.1186/s40001-020-00429-y |
_version_ | 1783564894314954752 |
---|---|
author | Öner, Alper Moerke, Caroline Wolff, Anne Kischkel, Sabine Schmidt, Wolfram Grabow, Niels Ince, Hüseyin |
author_facet | Öner, Alper Moerke, Caroline Wolff, Anne Kischkel, Sabine Schmidt, Wolfram Grabow, Niels Ince, Hüseyin |
author_sort | Öner, Alper |
collection | PubMed |
description | BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made of bare metal stents with a polytetrafluoroethylene (PTFE) or polyurethane coating. These stents’ major limitations include higher rates of thrombus formation and restenosis. Hence, there is a still unmet need for new stents regarding their design and composition. Or, to test new covered stent designs, the rabbit iliac artery has become the best-established animal model. This study sought to present a preclinical animal approach designed to test covered stents that are utilized following vessel perforation. METHODS: The animal experiments were performed using New Zealand white rabbits, each weighting 3.5–4.5 kg. The animal models described herein relied on the three most common clinical causes for CP, such as guidewire-induced, balloon catheter bursting, and device oversizing. Moreover, the sealing capacity of covered stent grafts was assessed for each of these models by means of angiography. RESULTS: We herein report a rabbit iliac artery perforation model using three different types of vessel perforation that closely mimic the clinical setting, such as guidewire-induced, balloon catheter rupture, and device oversizing. Using the same rabbit iliac perforation model, we additionally assessed the sealing capacity of a covered stent graft for each model. CONCLUSIONS: The novel rabbit iliac artery perforation models, as described in this report, represent promising animal testing approaches. While their setting is very similar to the real-life context encountered in humans, all three models are based on an animal model that is ideally suited for evaluating the sealing capacity and performance of new medical devices for humans. |
format | Online Article Text |
id | pubmed-7392678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73926782020-08-04 A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation Öner, Alper Moerke, Caroline Wolff, Anne Kischkel, Sabine Schmidt, Wolfram Grabow, Niels Ince, Hüseyin Eur J Med Res Research BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made of bare metal stents with a polytetrafluoroethylene (PTFE) or polyurethane coating. These stents’ major limitations include higher rates of thrombus formation and restenosis. Hence, there is a still unmet need for new stents regarding their design and composition. Or, to test new covered stent designs, the rabbit iliac artery has become the best-established animal model. This study sought to present a preclinical animal approach designed to test covered stents that are utilized following vessel perforation. METHODS: The animal experiments were performed using New Zealand white rabbits, each weighting 3.5–4.5 kg. The animal models described herein relied on the three most common clinical causes for CP, such as guidewire-induced, balloon catheter bursting, and device oversizing. Moreover, the sealing capacity of covered stent grafts was assessed for each of these models by means of angiography. RESULTS: We herein report a rabbit iliac artery perforation model using three different types of vessel perforation that closely mimic the clinical setting, such as guidewire-induced, balloon catheter rupture, and device oversizing. Using the same rabbit iliac perforation model, we additionally assessed the sealing capacity of a covered stent graft for each model. CONCLUSIONS: The novel rabbit iliac artery perforation models, as described in this report, represent promising animal testing approaches. While their setting is very similar to the real-life context encountered in humans, all three models are based on an animal model that is ideally suited for evaluating the sealing capacity and performance of new medical devices for humans. BioMed Central 2020-07-29 /pmc/articles/PMC7392678/ /pubmed/32727596 http://dx.doi.org/10.1186/s40001-020-00429-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Öner, Alper Moerke, Caroline Wolff, Anne Kischkel, Sabine Schmidt, Wolfram Grabow, Niels Ince, Hüseyin A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title | A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title_full | A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title_fullStr | A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title_full_unstemmed | A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title_short | A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
title_sort | preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392678/ https://www.ncbi.nlm.nih.gov/pubmed/32727596 http://dx.doi.org/10.1186/s40001-020-00429-y |
work_keys_str_mv | AT oneralper apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT moerkecaroline apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT wolffanne apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT kischkelsabine apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT schmidtwolfram apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT grabowniels apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT incehuseyin apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT oneralper preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT moerkecaroline preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT wolffanne preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT kischkelsabine preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT schmidtwolfram preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT grabowniels preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation AT incehuseyin preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation |